Evidence map›Paper›PMID 23303771›Full record

ArticleNucleic acids research2013

Rev3, the catalytic subunit of Polζ, is required for maintaining fragile site stability in human cells.

Audesh Bhat, Parker L Andersen, Zhoushuai Qin, Wei Xiao

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. REV7: Jack of many trades.Trends in cell biology · 2021
    Review
  14. Mind the replication gap.Royal Society open science · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Audesh BhatDepartment of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Canada S7N 5E5 and College of Life Sciences, Capital Normal University, Beijing, China 100048.
Parker L Andersen
Zhoushuai Qin
Wei Xiao
University of Saskatchewan · CACapital Normal University · CN

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

It has been long speculated that mammalian Rev3 plays an important, yet unknown role(s) during mammalian development, as deletion of Rev3 causes embryonic lethality in mice, whereas no other translesion DNA synthesis polymerases studied to date are required for mouse embryo development. Here, we report that both subunits of Polζ (Rev3 and Rev7) show an unexpected increase in expression during G(2)/M phase, but they localize independently in mitotic cells. Experimental depletion of Rev3 results in a significant increase in anaphase bridges, chromosomal breaks/gaps and common fragile site (CFS) expression, whereas Rev7 depletion primarily causes lagging chromosome defect with no sign of CFS expression. The genomic instability induced by Rev3 depletion seems to be related to replication stress, as it is further enhanced on aphidicolin treatment and results in increased metaphase-specific Fanconi anemia complementation group D type 2 (FANCD2) foci formation, as well as FANCD2-positive anaphase bridges. Indeed, a long-term depletion of Rev3 in cultured human cells results in massive genomic instability and severe cell cycle arrest. The aforementioned observations collectively support a notion that Rev3 is required for the efficient replication of CFSs during G(2)/M phase, and that the resulting fragile site instability in Rev3 knockout mice may trigger cell death during embryonic development.

Indexed as

Chromosome Fragile SitesCell DivisionCell ProliferationCells, CulturedChromosome BreakageDNA-Binding ProteinsDNA-Directed DNA PolymeraseFanconi Anemia Complementation Group D2 ProteinG2 PhaseGenomic InstabilityHistonesHumansMad2 ProteinsMitosisNucleic Acid Synthesis InhibitorsProteinsDNA-Binding ProteinsDNA-Directed DNA PolymeraseFanconi Anemia Complementation Group D2 ProteinH2AX protein, humanHistonesMAD2L2 protein, humanMad2 ProteinsNucleic Acid Synthesis InhibitorsProteinsREV3L protein, human

Identifiers

PMID23303771
PMCPMC3575803
OpenAlexW2136480614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.